Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer

Gynecologic Oncology

Volumn 128, Issue 2, 2013, Pages 288-293

  Folkert, Michael R ^a   Shih, Karin K ^a   Abu Rustum, Nadeem R ^a   Jewell, Elizabeth ^a   Kollmeier, Marisa A ^a   Makker, Vicky ^a   Barakat, Richard R ^a   Alektiar, Kaled M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Cervical cancer; Chemoradiation; IMRT; Intermediate or high risk; Postoperative

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CLINICAL PRACTICE; DISEASE FREE SURVIVAL; EARLY CANCER; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84872843530     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.11.012     Document Type: Article

References (23)

1. C. Loiselle, and W.J. Koh The emerging use of IMRT for treatment of cervical cancer J Natl Compr Canc Netw 8 2010 1425 1434
2. L.K. Mell, A.K. Mehrotra, and A.J. Mundt Intensity-modulated radiation therapy use in the U.S., 2004 Cancer 104 2005 1296 1303 (Pubitemid 41278966)
3. L.K. Mell, J.C. Roeske, and A.J. Mundt A survey of intensity-modulated radiation therapy use in the United States Cancer 98 2003 204 211 (Pubitemid 36741143)
4. L.K. Mell, J.D. Kochanski, J.C. Roeske, J.J. Haslam, N. Mehta, and S.D. Yamada Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy Int J Radiat Oncol Biol Phys 66 2006 1356 1365
5. A.J. Mundt, A.E. Lujan, J. Rotmensch, S.E. Waggoner, S.D. Yamada, and G. Fleming Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies Int J Radiat Oncol Biol Phys 52 2002 1330 1337 (Pubitemid 34296492)
6. A.J. Mundt, L.K. Mell, and J.C. Roeske Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy Int J Radiat Oncol Biol Phys 56 2003 1354 1360 (Pubitemid 36842887)
7. L. Portelance, K.S. Chao, P.W. Grigsby, H. Bennet, and D. Low Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation Int J Radiat Oncol Biol Phys 51 2001 261 266 (Pubitemid 32758886)
8. J.C. Roeske, D. Bonta, L.K. Mell, A.E. Lujan, and A.J. Mundt A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy Radiother Oncol 69 2003 201 207 (Pubitemid 37485881)
9. J.C. Roeske, A. Lujan, J. Rotmensch, S.E. Waggoner, D. Yamada, and A.J. Mundt Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies Int J Radiat Oncol Biol Phys 48 2000 1613 1621
10. M.F. Chen, C.J. Tseng, C.C. Tseng, C.Y. Yu, C.T. Wu, and W.C. Chen Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients Cancer J 14 2008 200 206
11. M.D. Hasselle, B.S. Rose, J.D. Kochanski, S.K. Nath, R. Bafana, and C.M. Yashar Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix Int J Radiat Oncol Biol Phys 80 2011 1436 1445
12. A. Sedlis, B.N. Bundy, M.Z. Rotman, S.S. Lentz, L.I. Muderspach, and R.J. Zaino A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study Gynecol Oncol 73 1999 177 183 (Pubitemid 29215728)
13. W.A. Peters 3rd, P.Y. Liu, R.J. Barrett 2nd, R.J. Stock, B.J. Monk, and J.S. Berek Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix J Clin Oncol 18 2000 1606 1613 (Pubitemid 30220538)
14. RTOG 0418. A phase II study of intensity modulated radiation therapy (IMRT) to the pelvis ± chemotherapy for post-operative patients with either endometrial or cervical carcinoma.
15. W. Small Jr., L.K. Mell, P. Anderson, C. Creutzberg, J. De Los Santos, and D. Gaffney Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer Int J Radiat Oncol Biol Phys 71 2008 428 434 (Pubitemid 351636192)
16. E. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Statist Assoc 53 1958 457 481
17. E. Wilson Probable inference, the law of succession, and statistical inference J Am Statist Assoc 22 1927 209 212
18. M. Rotman, A. Sedlis, M.R. Piedmonte, B. Bundy, S.S. Lentz, and L.I. Muderspach A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a Gynecologic Oncology Group study Int J Radiat Oncol Biol Phys 65 2006 169 176
19. Y. Ohba, Y. Todo, N. Kobayashi, M. Kaneuchi, H. Watari, and M. Takeda Risk factors for lower-limb lymphedema after surgery for cervical cancer Int J Clin Oncol 16 2011 238 243
20. A.E. Lujan, A.J. Mundt, S.D. Yamada, J. Rotmensch, and J.C. Roeske Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy Int J Radiat Oncol Biol Phys 57 2003 516 521 (Pubitemid 37040950)
21. A. Klopp, J. Moughan, L. Portelance, B. Miller, M. Salehpour, and D. D'Souza Hematologic toxicity on RTOG 0418: a phase II study of post-operative IMRT for gynecologic cancer Int J Radiat Oncol Biol Phys 78 2010 S121
22. M.F. Chen, C.J. Tseng, C.C. Tseng, Y.C. Kuo, C.Y. Yu, and W.C. Chen Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy Int J Radiat Oncol Biol Phys 67 2007 1438 1444
23. L. Portelance, J. Moughan, A. Jhingran, B. Miller, M. Salehpour, and D. D'Souza A phase II multi-institutional study of postoperative pelvic intensity modulated radiation therapy (IMRT) with weekly cisplatin in patients with cervical carcinoma: two year efficacy results of the RTOG 0418 Int J Radiat Oncol Biol Phys 81 2011 S3